3D Global Biotech Inc. (TPEX:6808)

Market Cap	2.02B -43.8%
Revenue (ttm)	159.19M -51.0%
Net Income	14.20M -89.4%
EPS	0.18 -89.2%
Shares Out	76.98M
PE Ratio	142.53
Forward PE	n/a
Dividend	0.10 (0.38%)
Ex-Dividend Date	Jul 16, 2026

Volume	72,541
Open	25.30
Previous Close	25.90
Day's Range	24.90 - 26.45
52-Week Range	22.45 - 51.50
Beta	0.18
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About 3D Global Biotech

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 43
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6808

Financial Performance

In 2025, 3D Global Biotech's revenue was 206.74 million, a decrease of -22.19% compared to the previous year's 265.69 million. Earnings were 66.53 million, a decrease of -27.45%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error